QTRX Quanterix Corporation
Healthcare$2.69+1.89%ClosedMarket Cap: $126.7M
As of 2026-05-25
Valuation
P/E (TTM)
—
PEG
—
P/B
0.45
P/S
0.87
EV/EBITDA
-1.40
DCF Value
$-22.03
FCF Yield
-65.4%
Div Yield
0.0%
Margins & Returns
Gross Margin
44.1%
Operating Margin
-82.7%
Net Margin
-71.9%
ROE
-35.2%
ROA
-28.4%
ROIC
-36.1%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $36.4M | 42.7% | $-21.5M | $-17.5M | $— | — |
| Q4 null | $43.9M | 45.5% | $-23.9M | $-23.1M | $— | — |
| FY null | $138.7M | 46.7% | $-109.8M | $-107.2M | $— | — |
| Q3 null | $40.1M | 42.6% | $-37.3M | $-33.5M | $— | — |
| Q2 null | $24.5M | 46.1% | $-37.1M | $-30.0M | $— | — |
| Q1 null | $30.3M | 54.0% | $-26.4M | $-20.5M | $— | — |
| Q4 null | $34.1M | 61.9% | $-14.8M | $-11.6M | $— | — |
| FY null | $135.4M | 59.9% | $-52.6M | $-38.5M | $— | — |
| Q3 null | $35.4M | 55.8% | $-11.7M | $-8.4M | $— | — |
| Q2 null | $34.1M | 64.4% | $-10.9M | $-7.4M | $— | — |
| Q1 null | $31.8M | 57.5% | $-15.2M | $-11.2M | $— | — |
| Q4 2023 | $31.2M | 52.7% | $-16.9M | $-12.4M | $-0.33 | — |